ByTrending Posts
XtalPi and Janssen Partner to Accelerate AI-Driven Small…
Shenzhen, China – Oct 27 2022 XtalPi Inc., a leading AI-powered pharmaceutical technology company, announced a strategic research…
GSK Expands AI Capabilities with $70 Million Tempus…
London, UK – October 18, 2022 GSK has entered into a $70 million agreement with Tempus, a leader…
Eli Lilly and Genesis AI Announce $670M AI-Driven…
BURLINGAME, California – May 3, 2022 Harnessing AI to Unlock Breakthrough Therapies Eli Lilly and Company and Genesis…
Genesis AI and Genentech (Roche) Form Multi-Target AI…
BURLINGAME, California – Oct 19, 2020 Genesis Therapeutics, a pioneer in AI-driven drug discovery, has announced a multi-target…
Trending Posts
Latest Stories
How Is Pfizer Expanding Its Oncology Pipeline Through T-Cell–Targeted Immunotherapy for Prostate Cancer?
Cambridge, Massachusetts Pfizer is strengthening its oncology research pipeline through a new program launched under…
Will AI-Powered Prior Authorization Change How Medicare Care Is Delivered?
December 2025 — Medicare is preparing to introduce artificial intelligence–driven prior authorization reviews for certain…
Did 2025 Expose the Breaking Point of America’s Health Care System?
New reflections from healthcare leaders highlight how events in 2025 revealed deep structural weaknesses in…
How Is Senhwa Biosciences Using AI and Strategic Collaborations to Shape the Next Generation of Immuno-Oncology?
TAIPEI and SAN DIEGO — Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on first-in-class…
Gallery
